Repron Therapeutics

About:

Repron provides treatments for solid tumour cases where radical excision is not possible and metastasis or recurrence is extremely likely.

Website: https://www.reprontherapeutics.com/

Top Investors: Claris Ventures

Description:

Repron Therapeutics provides treatments for solid tumor cases where radical excision is not possible and metastasis or recurrence is extremely likely.

Total Funding Amount:

2M EUR

Headquarters Location:

Milano, Lombardia, Italy

Founded Date:

2023-01-01

Contact Email:

info(AT)reprontherapeutics.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai